Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $362
Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344
Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $335
Bernstein Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Navigating 14 Analyst Ratings For Amgen
TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $383
Amgen Analyst Ratings
Goldman Sachs Maintains Amgen(AMGN.US) With Buy Rating
A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $335 to $381
DBS Maintains Amgen(AMGN.US) With Buy Rating
Jefferies Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Jefferies Remains a Buy on Amgen (AMGN)
Amgen Analyst Ratings
Truist Financial Downgrades Amgen(AMGN.US) to Hold Rating, Announces Target Price $333
Morgan Stanley Adjusts Price Target on Amgen to $319 From $316
Morgan Stanley Keeps Their Hold Rating on Amgen (AMGN)
Amgen Analyst Ratings
Barclays Keeps Their Hold Rating on Amgen (AMGN)